GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ZYUS Life Sciences Corp (TSXV:ZYUS) » Definitions » Price-to-Tangible-Book

ZYUS Life Sciences (TSXV:ZYUS) Price-to-Tangible-Book : 14.78 (As of May. 26, 2024)


View and export this data going back to 2023. Start your Free Trial

What is ZYUS Life Sciences Price-to-Tangible-Book?

As of today (2024-05-26), ZYUS Life Sciences's share price is C$1.02. ZYUS Life Sciences's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was C$0.07. Hence, ZYUS Life Sciences's Price to Tangible Book Ratio of today is 14.78.

The historical rank and industry rank for ZYUS Life Sciences's Price-to-Tangible-Book or its related term are showing as below:

TSXV:ZYUS' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 13.04   Med: 13.04   Max: 14.78
Current: 14.57

During the past 3 years, ZYUS Life Sciences's highest Price to Tangible Book Ratio was 14.78. The lowest was 13.04. And the median was 13.04.

TSXV:ZYUS's Price-to-Tangible-Book is ranked worse than
93.53% of 865 companies
in the Drug Manufacturers industry
Industry Median: 2.32 vs TSXV:ZYUS: 14.57

A closely related ratio is called PB Ratio. As of today, ZYUS Life Sciences's share price is C$1.02. ZYUS Life Sciences's Book Value per Sharefor the quarter that ended in Dec. 2023 was C$0.33. Hence, ZYUS Life Sciences's P/B Ratio of today is 3.13.


ZYUS Life Sciences Price-to-Tangible-Book Historical Data

The historical data trend for ZYUS Life Sciences's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ZYUS Life Sciences Price-to-Tangible-Book Chart

ZYUS Life Sciences Annual Data
Trend Dec21 Dec22 Dec23
Price-to-Tangible-Book
- - 13.04

ZYUS Life Sciences Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only - - 9.47 12.50 13.04

Competitive Comparison of ZYUS Life Sciences's Price-to-Tangible-Book

For the Drug Manufacturers - Specialty & Generic subindustry, ZYUS Life Sciences's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ZYUS Life Sciences's Price-to-Tangible-Book Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, ZYUS Life Sciences's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where ZYUS Life Sciences's Price-to-Tangible-Book falls into.



ZYUS Life Sciences Price-to-Tangible-Book Calculation

ZYUS Life Sciences's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Dec. 2023 )
=1.02/0.069
=14.78

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


ZYUS Life Sciences Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of ZYUS Life Sciences's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


ZYUS Life Sciences (TSXV:ZYUS) Business Description

Traded in Other Exchanges
Address
407 Downey Road, Unit 204, Saskatoon, SK, CAN, S7N 4L8
ZYUS Life Sciences Corp is a next-generation life sciences company engaged in scientific research and development in phyto-therapeutics, including cannabinoid and protein-based formulations. It is committed to delivering high-quality standardized therapeutic formulations that comply with Good Manufacturing Practices (GMP) to provide targeted relief for patients in Canada and globally.
Executives
John Michael Hyshka Senior Officer

ZYUS Life Sciences (TSXV:ZYUS) Headlines

No Headlines